AU1022195A - Cytokine antibody for the treatment of sepsis - Google Patents

Cytokine antibody for the treatment of sepsis

Info

Publication number
AU1022195A
AU1022195A AU10221/95A AU1022195A AU1022195A AU 1022195 A AU1022195 A AU 1022195A AU 10221/95 A AU10221/95 A AU 10221/95A AU 1022195 A AU1022195 A AU 1022195A AU 1022195 A AU1022195 A AU 1022195A
Authority
AU
Australia
Prior art keywords
sepsis
treatment
cytokine antibody
cytokine
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10221/95A
Inventor
Lucien A Aarden
Abla A. Creasey
Kirston E. Koths
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cetus Oncology Corp
Original Assignee
Cetus Oncology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Oncology Corp filed Critical Cetus Oncology Corp
Publication of AU1022195A publication Critical patent/AU1022195A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/243—Colony Stimulating Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/248—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU10221/95A 1989-12-15 1995-01-16 Cytokine antibody for the treatment of sepsis Abandoned AU1022195A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45121889A 1989-12-15 1989-12-15
US451218 1989-12-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU71603/91A Division AU7160391A (en) 1989-12-15 1990-12-13 Cytokine antibody for the treatment of sepsis

Publications (1)

Publication Number Publication Date
AU1022195A true AU1022195A (en) 1995-04-27

Family

ID=23791295

Family Applications (2)

Application Number Title Priority Date Filing Date
AU71603/91A Abandoned AU7160391A (en) 1989-12-15 1990-12-13 Cytokine antibody for the treatment of sepsis
AU10221/95A Abandoned AU1022195A (en) 1989-12-15 1995-01-16 Cytokine antibody for the treatment of sepsis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU71603/91A Abandoned AU7160391A (en) 1989-12-15 1990-12-13 Cytokine antibody for the treatment of sepsis

Country Status (5)

Country Link
EP (1) EP0506855A1 (en)
JP (1) JPH05503098A (en)
AU (2) AU7160391A (en)
CA (1) CA2071872A1 (en)
WO (1) WO1991008774A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246701A (en) * 1990-10-05 1993-09-21 Ludwig Institute For Cancer Research Method for inhibiting production of IgE by using IL-9 inhibitors
WO1994009138A1 (en) * 1992-10-20 1994-04-28 Cetus Oncology Corporation Interleukin-6 receptor antagonists
JP3525221B2 (en) * 1993-02-17 2004-05-10 味の素株式会社 Immunosuppressants
ATE420955T1 (en) 1993-07-20 2009-01-15 Univ California REGULATION OF TRANSCRIPTION FACTOR, NF-IL6/LAP
US5993811A (en) 1997-02-03 1999-11-30 Biology Associates, Llc Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
US7494652B1 (en) * 1998-06-10 2009-02-24 Promega Corporation Treatment of sepsis
US7108852B2 (en) 2000-03-20 2006-09-19 Warner-Lambert Company Llc Methods of treating inflammation using antibodies to M-CSF
CN100374457C (en) 2001-11-14 2008-03-12 森托科尔公司 Anti-IL-6 antibodies, compositions, methods and uses
AR045563A1 (en) 2003-09-10 2005-11-02 Warner Lambert Co ANTIBODIES DIRECTED TO M-CSF
HUE039803T2 (en) 2004-01-07 2019-02-28 Novartis Vaccines & Diagnostics Inc M-csf-specific monoclonal antibody and uses thereof
PE20061324A1 (en) 2005-04-29 2007-01-15 Centocor Inc ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES
US8188235B2 (en) 2008-06-18 2012-05-29 Pfizer Inc. Antibodies to IL-6 and their uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0111344A2 (en) * 1982-12-13 1984-06-20 Sloan-Kettering Institute For Cancer Research Anti-interleukin-2 monoclonal antibodies
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
GB8624899D0 (en) * 1986-10-17 1986-11-19 Sandoz Ltd Monoclonal antibodies
DK590387A (en) * 1986-11-13 1988-05-14 Otsuka Pharma Co Ltd ANTIBODIES AGAINST INTERLEUKIN-1

Also Published As

Publication number Publication date
CA2071872A1 (en) 1991-06-16
EP0506855A1 (en) 1992-10-07
WO1991008774A1 (en) 1991-06-27
JPH05503098A (en) 1993-05-27
AU7160391A (en) 1991-07-18

Similar Documents

Publication Publication Date Title
AU5267190A (en) Modified antibodies
AU1480388A (en) Altered antibodies
AU6698390A (en) Multi-layered dressing
AU1716292A (en) Assay of specific antibody
AU1022195A (en) Cytokine antibody for the treatment of sepsis
AU2097592A (en) Fibrinogen-specific monoclonal antibody and uses thereof
AU3330689A (en) Monoclonal antibodies
AU4450389A (en) Anti-fucosylcermiade monoclonal antibody
AU6725190A (en) Anti-platelet monoclonal antibody
AU2970989A (en) Process for the preparation of urea
AU1501592A (en) Process for the preparation of hydrocarbons
AU2752888A (en) Use of known compounds, novel compounds and the use and processes for preparation thereof
AU5210390A (en) Color-former
AU3663789A (en) Process for the preparation of substituted anilides
AU624262B2 (en) Use of prophenytoin for treating stroke
AU618720B2 (en) Monoclonal antibodies
AU6255690A (en) Opaliform porcellanite and process for the preparation thereof
AU7934791A (en) Process for the preparation of hydrocarbons
AU7862291A (en) Modified antibodies
AU6063290A (en) Multifibre connectorisation
FI943660A0 (en) Process for the preparation of 3-carbonylandrostadiene-17-carboxamides
AU6269190A (en) Antibodies and proteins
AU6964891A (en) Novel monoclonal antibody against human platelets
AU3698789A (en) Antibodies
AU6840690A (en) Process for the preparation of glycosylanthracyclinones